Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N H Georgopapadakou

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Idrugs : the Investigational Drugs Journal|October 4, 2005
Fungal diagnostics, pathogenesis and chemotherapy symposiaN H Georgopapadakou
Expert Opinion on Investigational Drugs|February 15, 2001
Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitorsN H Georgopapadakou
Expert Opinion on Investigational Drugs|November 4, 2000
Antifungals targeted to sphingolipid synthesis: focus on inositol phosphorylceramide synthaseN H Georgopapadakou
Antimicrobial Agents and Chemotherapy|October 1, 1993
Penicillin-binding proteins and bacterial resistance to beta-lactamsN H Georgopapadakou
Current Opinion in Microbiology|March 6, 1999
Antifungals: mechanism of action and resistance, established and novel drugsN H Georgopapadakou
Journal of Chemotherapy (Florence, Italy)|October 1, 1990
Antibiotic permeation through the bacterial outer membraneN H Georgopapadakou
Antimicrobial Agents and Chemotherapy|August 1, 1996
Does cephalothin inhibit matrix metalloproteinases?N H Georgopapadakou
Expert Opinion on Investigational Drugs|February 1, 1997
Antifungals targeted to the cell wallN H Georgopapadakou
Antimicrobial Agents and Chemotherapy|March 1, 1993
Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coliN H Georgopapadakou, A Bertasso
Antimicrobial Agents and Chemotherapy|August 1, 1992
Effects of squalene epoxidase inhibitors on Candida albicansN H Georgopapadakou, A Bertasso
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Idrugs : the Investigational Drugs Journal|October 4, 2005
Fungal diagnostics, pathogenesis and chemotherapy symposiaN H Georgopapadakou
Expert Opinion on Investigational Drugs|February 15, 2001
Update on antifungals targeted to the cell wall: focus on beta-1,3-glucan synthase inhibitorsN H Georgopapadakou
Expert Opinion on Investigational Drugs|November 4, 2000
Antifungals targeted to sphingolipid synthesis: focus on inositol phosphorylceramide synthaseN H Georgopapadakou
Antimicrobial Agents and Chemotherapy|October 1, 1993
Penicillin-binding proteins and bacterial resistance to beta-lactamsN H Georgopapadakou
Current Opinion in Microbiology|March 6, 1999
Antifungals: mechanism of action and resistance, established and novel drugsN H Georgopapadakou
Journal of Chemotherapy (Florence, Italy)|October 1, 1990
Antibiotic permeation through the bacterial outer membraneN H Georgopapadakou
Antimicrobial Agents and Chemotherapy|August 1, 1996
Does cephalothin inhibit matrix metalloproteinases?N H Georgopapadakou
Expert Opinion on Investigational Drugs|February 1, 1997
Antifungals targeted to the cell wallN H Georgopapadakou
Antimicrobial Agents and Chemotherapy|March 1, 1993
Mechanisms of action of cephalosporin 3'-quinolone esters, carbamates, and tertiary amines in Escherichia coliN H Georgopapadakou, A Bertasso
Antimicrobial Agents and Chemotherapy|August 1, 1992
Effects of squalene epoxidase inhibitors on Candida albicansN H Georgopapadakou, A Bertasso
Pageof 6